Breaking News Instant updates and real-time market news.

2022-01-27 07:12:27 MKTX MarketAxess $332.45 / -20.48 (-5.80%) 07:12 01/27/22 01/27 07:12 01/27/22 07:12	MarketAxess price target raised to $375 from $369 at Deutsche Bank Deutsche Bank analyst Brian Bedell raised the firm's price target on MarketAxess to $375 from $369 and keeps a Hold rating on the shares following the "good" Q4 results.	16 Feb

2022-01-27 07:12:27

MKTX

MarketAxess

$332.45 / -20.48 (-5.80%)

07:12

01/27/22

01/27

07:12

01/27/22

07:12

MarketAxess price target raised to $375 from $369 at Deutsche Bank

Deutsche Bank analyst Brian Bedell raised the firm's price target on MarketAxess to $375 from $369 and keeps a Hold rating on the shares following the "good" Q4 results.

16
Feb

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Urban-Gro appoints Arie Kamp as managing director, urban-gro Europe » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 UGRO Urban-Gro $6.22 / +0.075 (+1.22%) urban-gro announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 05/11/22 Urban Gro Inc trading resumes 05/11/22 Urban Gro Inc trading halted, volatility trading pause 05/02/22 Urban-Gro closes acquisition of Emerald Construction Management 04/22/22 Urban-Gro partners with Teens for Food Justice UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 05/02/22 Craig-Hallum Craig-Hallum bullish on Urban-Gro, initiates with a Buy 05/02/22 Craig-Hallum Urban-Gro initiated with a Buy at Craig-Hallum 03/21/22 Maxim Urban-Gro initiated with a Buy at Maxim 03/21/22 Maxim Urban-Gro initiated with a Buy at Maxim UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 03/29/22 Urban-Gro sees FY22 revenue greater than $110M, consensus $93.79M 03/29/22 Urban-Gro reports Q4 EPS (6c), consensus (4c) 01/05/22 Urban-Gro sees 2021 revenue $62M, one est. $64.67M. UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 Fly Intel: After-Hours Movers 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 urban-gro, Inc.
Hot Stocks	JPMorgan's Jamie Dimon on Investor Day: 'We should have done this earlier' » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 JPM JPMorgan $117.34 / -0.945 (-0.80%) Comments taken from the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JPM JPMorgan $117.34 / -0.945 (-0.80%) 06:17 Today JPMorgan sees 12.5%-13% CET1 ratio at 1Q24 06:17 Today JPMorgan sees FY22 NII excluding Markets $56B+ vs. previous $53B+ view 05/13/22 Soros buys Lucid, exits GM in Q1 05/10/22 JPMorgan launches new data plaform for the buy-side JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/13/22 Jefferies JPMorgan price target lowered to $125 from $141 at Jefferies 05/03/22 Oppenheimer Oppenheimer upgrades JPMorgan to Outperform on recent share weakness 05/03/22 Oppenheimer JPMorgan upgraded to Outperform from Perform at Oppenheimer 04/14/22 Argus JPMorgan price target lowered to $155 from $177 at Argus JPM JPMorgan $117.34 / -0.945 (-0.80%) 04/13/22 JPMorgan reports Q1 EPS $2.63, consensus $2.69 04/12/22 Notable companies reporting before tomorrow's open 04/12/22 Notable companies reporting before tomorrow's open 01/14/22 JPMorgan reports Q4 EPS $3.33, consensus $3.01 JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/19/22 BlackRock, JPMorgan tell Texas they're not boycotting energy firms, Reuters says 05/18/22 JPMorgan investors reject Dimon's $50M bonus, WSJ reports 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 05/08/22 Ford to sell 8M shares of Rivian with lockup expiring, CNBC reports JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/14/22 Opening Day: Fracking company ProFrac comes public in downsized IPO 05/09/22 What You Missed This Week in EVs and Clean Energy 05/03/22 What You Missed On Wall Street On Tuesday 05/03/22 What You Missed On Wall Street This Morning 00:00 Today 50th Annual Global Technology, Media & Communications Conference 07/14/22 JPMorgan - JPM 08:00 Today JPMorgan JPM JPMorgan $117.34 / -0.945 (-0.80%) 04/14/22 Notable open interest changes for April 14th 02/08/22 Early notable gainers among liquid option names on February 8th 01/14/22 Unusually active option classes on open January 14th 01/04/22 Unusually active option classes on open January 4th
Hot Stocks	Armata Pharmaceuticals doses first patient in Phase 1b/2a study of AP-SA02 » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) Armata Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Options ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) 02/22/22 Armata Pharmaceuticals: FDA clears IND application for AP-PA02 02/09/22 Armata Pharmaceuticals enters securities purchase agreement with Innoviva unit 01/05/22 Armata Pharmaceuticals provides update on pseudomonas respiratory programs ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) 03/17/22 Armata Pharmaceuticals reports Q4 EPS (23c), consensus (28c) ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) 01/20/22 Fifteen new option listings and one option delisting on January 20th
Recommendations	Teleflex price target lowered to $380 from $390 at RBC Capital » 08:08 05/23/22 05/23 08:08 05/23/22 08:08 TFX Teleflex $287.05 / -1.55 (-0.54%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TFX Teleflex $287.05 / -1.55 (-0.54%) 05/19/22 Teleflex announces regulatory clearance for UroLift System in China 05/18/22 Teleflex's Manta Vascular Closure Device approved by Health Canada 05/13/22 Teleflex announces full U.S. commercial launch of UroLift 2, UroLift ATC 04/11/22 Teleflex announces launch of UroLift System in Japan TFX Teleflex $287.05 / -1.55 (-0.54%) 05/09/22 BofA Teleflex initiated with a Neutral at BofA 04/29/22 Truist Teleflex price target lowered to $340 from $370 at Truist 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Teleflex initiated with a Hold at Truist TFX Teleflex $287.05 / -1.55 (-0.54%) 04/28/22 Teleflex still sees FY22 EPS $13.70-$14.30, consensus $13.89 04/28/22 Teleflex reports Q1 adjusted EPS $2.88, consensus $2.75 02/24/22 Teleflex sees FY22 adjusted EPS $13.70-$14.30, consensus $14.04 02/24/22 Teleflex reports Q4 adjusted EPS $3.60, consensus $3.53 TFX Teleflex $287.05 / -1.55 (-0.54%) 05/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/16/22 Teleflex
Hot Stocks	DZS to discuss 100G-enabled optical broadband networks at FTTH Conference » 08:07 05/23/22 05/23 08:07 05/23/22 08:07 DZSI DZS $14.53 / -0.08 (-0.55%) DZS announced that chief… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DZSI DZS $14.53 / -0.08 (-0.55%) 05/20/22 DZS announces Convergenze to deploy XGS-PON technology 05/02/22 DZS to acquire specific core assets of Adaptive Spectrum and Signal Alignment 04/29/22 DZS CTO to present at CommsDay Summit 2022 04/26/22 DZS announces ongoing partnership with Northeast Nebraska Telephone Company DZSI DZS $14.53 / -0.08 (-0.55%) 05/04/22 B. Riley DZS price target lowered to $24 from $25 at B. Riley 02/28/22 Stifel DZS resumed with a Buy at Stifel 02/14/22 B. Riley DZS price target raised to $25 from $22 at B. Riley 06/22/21 Needham DZS initiated with a Buy at Needham DZSI DZS $14.53 / -0.08 (-0.55%) 05/02/22 DZS sees FY22 revenue $380M-$410M, consensus $395.63M 05/02/22 DZS sees Q1 revenue $85M-$100M, consensus $92.47M 05/02/22 DZS reports Q1 EPS 1c, consensus (3c) 02/10/22 DZS sees FY22 revenue $380M-$410M, consensus $373.13M 05/25/22 22nd Annual Institutional Investor Conference 06/01/22 50th Annual Technology, Media & Telecom Conference 06/02/22 DZS Inc

Hot Stocks	Teva announces new efficacy, safety data from OLE study on Austedo tablets » 08:07 05/23/22 05/23 08:07 05/23/22 08:07 TEVA Teva $8.48 / +0.18 (+2.17%) Teva Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TEVA Teva $8.48 / +0.18 (+2.17%) 05/19/22 Teva EVP of R&D sells $1.07M in common stock 05/17/22 Teva granted license by MHRA for Ongavia 05/17/22 Teva announces new findings for ProAir Digihaler inhalation powder 05/10/22 Teva publishes 2021 ESG Progess Report TEVA Teva $8.48 / +0.18 (+2.17%) 05/17/22 BofA Teva upgraded to Neutral at BofA on potential opioid deal upside 05/17/22 BofA Teva upgraded to Neutral from Underperform at BofA 05/04/22 Piper Sandler Teva downgraded to Underweight from Neutral at Piper Sandler 04/05/22 Barclays Teva upgraded to Overweight from Equal Weight at Barclays TEVA Teva $8.48 / +0.18 (+2.17%) 05/03/22 Teva backs FY22 adjusted EPS view $2.40-$2.60, consensus $2.51 05/03/22 Teva reports Q1 EPS 55c, consensus 55c 02/09/22 Teva sees FY22 EPS $2.40-$2.60, consensus $2.64 02/09/22 Teva reports Q4 EPS 77c, consensus 73c TEVA Teva $8.48 / +0.18 (+2.17%) 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 12/30/21 Jury finds Teva fueled opioid addiction in NY, Reuters reports 12/30/21 Teva held liable by jury in New York in opioid trial, Bloomberg reports TEVA Teva $8.48 / +0.18 (+2.17%) 05/10/22 What You Missed On Wall Street On Tuesday 05/04/22 What You Missed On Wall Street On Wednesday 05/04/22 What You Missed On Wall Street This Morning 04/20/22 Fly Intel: Pre-market Movers 06/30/22 PDUFA Date for TV-46000/mdc-IRM TEVA Teva $8.48 / +0.18 (+2.17%) 05/11/22 Unusually active option classes on open May 11th 05/04/22 Teva put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 04/04/22 Teva call volume above normal and directionally bullish
Hot Stocks	Liminal BioSciences doses first subject in Phase 1a trial of fezagepras » 08:07 05/23/22 05/23 08:07 05/23/22 08:07 LMNL Liminal BioSciences / + Liminal BioSciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research LMNL Liminal BioSciences / + 03/14/22 Liminal BioSciences provides update on lead drug candidate fezagepras 03/07/22 Liminal BioSciences receives Nasdaq deficiency notice over bid price LMNL Liminal BioSciences / + 06/24/21 Fly Intel: Top five analyst downgrades 06/24/21 H.C. Wainwright Liminal BioSciences downgraded to Neutral from Buy at H.C. Wainwright 06/02/21 Fly Intel: Top five analyst downgrades 06/01/21 Piper Sandler Liminal BioSciences downgraded to Neutral from Overweight at Piper Sandler
Hot Stocks	Inspired Entertainment receives igaming license in Pennsylvania » 08:06 05/23/22 05/23 08:06 05/23/22 08:06 INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) Inspired Entertainment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 04/12/22 Inspired Entertainment awarded additional 700 VLTs in Saskatchewan 03/11/22 Inspired Entertainment expects to file Form 12b-25 with SEC 03/04/22 Inspired Entertainment launches igaming content with DraftKings in Connecticut 02/08/22 Inspired Entertainment launches igaming content with Gan Limited in Michigan INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 11/29/21 B. Riley B. Riley says focus on domestic gaming suppliers with Macau 'broken' 09/09/21 Macquarie Macquarie says own online gaming into 'major catalyst' of NFL kickoff 07/23/21 Truist Truist starts Inspired Entertainment at Buy citing 'high-growth' Virtual Sports 07/23/21 Truist Inspired Entertainment initiated with a Buy at Truist INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 05/10/22 Inspired Entertainment reports Q1 GAAP EPS 5c, consensus (9c) 03/11/22 Inspired Entertainment reports Q4 GAAP EPS (5c), consensus 5c 26 May INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 03/04/22 Bet On It: Missouri House Committee pushes forward sports betting bill 02/11/22 Bet On It: Nationwide legalization efforts lead to record wagers for Super Bowl 05/25/22 22nd Annual Institutional Investor Conference 06/01/22 Inspired Entertainment 06/02/22 Inspired Entertainment 06/03/22 Inspired Entertainment
Hot Stocks	Bowlero announces agreement to acquire three bowling centers in Kansas » 08:05 05/23/22 05/23 08:05 05/23/22 08:05 BOWL Bowlero $9.49 / -0.225 (-2.32%) Bowlero announced today… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options BOWL Bowlero $9.49 / -0.225 (-2.32%) 05/12/22 Bowlero rises 8.8% 04/14/22 Bowlero announces redemption of all outstanding warrants 02/11/22 Soros Fund buys Rivian, exits Coupang in Q4 02/10/22 Bowlero rises 18.1% BOWL Bowlero $9.49 / -0.225 (-2.32%) 02/16/22 Noble Capital Bowlero initiated with an Outperform at Noble Capital 10/12/21 MKM Partners MKM starts Isos Acquisition with Buy ahead of Bowlero merger 10/11/21 MKM Partners Bowlero partner Isos Acquisition initiated with a Buy at MKM Partners BOWL Bowlero $9.49 / -0.225 (-2.32%) 02/09/22 Bowlero reports Q2 adjusted EBITDA $66.8M, up 26% y/y 00:00 Today 50th Annual Global Technology, Media & Communications Conference BOWL Bowlero $9.49 / -0.225 (-2.32%) 04/27/22 Three new option listings on April 27th
Hot Stocks	Satellogic announces enhanced operations in Australia to serve the APAC region » 08:05 05/23/22 05/23 08:05 05/23/22 08:05 SATL Satellogic $5.29 / -0.19 (-3.47%) Satellogic announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options SATL Satellogic $5.29 / -0.19 (-3.47%) 05/04/22 Satellogic up 21% after announcing launch agreement with SpaceX 05/04/22 Satellogic signs new multiple launch agreement with SpaceX 04/25/22 Satellogic partners with Orbital Insight for high-resolution satellite imagery 04/04/22 Satellogic launches five additional spacecraft on SpaceX Transporter-4 mission SATL Satellogic $5.29 / -0.19 (-3.47%) 05/10/22 Piper Sandler Satellogic initiated with an Underweight at Piper Sandler SATL Satellogic $5.29 / -0.19 (-3.47%) 05/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/04/22 Fly Intel: Pre-market Movers SATL Satellogic $5.29 / -0.19 (-3.47%) 03/25/22 Three new option listings on March 25th

Hot Stocks	AbbVie's cariprazine for MDD achieves primary endpoint in Phase 3 study » 08:05 05/23/22 05/23 08:05 05/23/22 08:05 ABBV AbbVie $151.04 / -0.8 (-0.53%) , RGEDF Richter Gedeon $24.63 / + (+0.00%) AbbVie (ABBV) will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 05:26 Today AbbVie receives CHMP recommendation for upadacitinib approval 05/20/22 AbbVie submits NDA to FDA for ABBV-951 05/16/22 Berkshire Hathaway adds Citi, exits Wells Fargo in Q1 05/16/22 AbbVie, Cugene announce collaboration in autoimmune diseases ABBV RGEDF ABBV AbbVie $151.04 / -0.8 (-0.53%) 06:23 Today SVB Leerink AbbVie initiated with an Underperform at SVB Leerink 05/13/22 Piper Sandler Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler 05/06/22 Daiwa AbbVie downgraded to Neutral from Outperform at Daiwa 05/03/22 Morgan Stanley Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure RGEDF Richter Gedeon $24.63 / + (+0.00%) ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 04/29/22 AbbVie sees FY22 revenue $59.4B, consensus $60.22B 04/29/22 AbbVie sees Q2 adjusted EPS $3.38-$3.42, consensus $3.50 04/29/22 AbbVie cuts FY22 adjusted EPS view to $13.92-$14.12 from $14.00-$14.20 04/29/22 AbbVie reports Q1 adjusted EPS $3.16, consensus $3.14 ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 03/07/22 Johnson & Johnson negotiating deals with two Chinese companies, FT reports ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 05/10/22 What You Missed On Wall Street On Tuesday 05/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/29/22 What You Missed On Wall Street On Friday 06/02/22 38th Annual Strategic Decisions Conference 06/03/22 2022 ASCO Annual Meeting 09/07/22 2022 Wells Fargo Healthcare Conference ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 04/29/22 Unusually active option classes on open April 29th 02/24/22 AbbVie put volume heavy and directionally bearish 01/24/22 AbbVie put volume heavy and directionally bearish 12/06/21 Unusually active option classes on open December 6th
Initiation	Tabcorp initiated with a Hold at Jefferies » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 TACBY Tabcorp $7.42 / + (+0.00%) Jefferies analyst Simon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TACBY Tabcorp $7.42 / + (+0.00%) 07/19/21 Goldman Sachs Tabcorp reinstated with a Buy at Goldman Sachs 07/06/21 CLSA Tabcorp downgraded to Outperform from Buy at CLSA
Hot Stocks	Hyundai Motor increases U.S. investment » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) Hyundai Motor Group is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) 05/22/22 Hyundai Motor to invest more than $10 billion in U.S. by 2025 05/20/22 Hyundai Motor announces pact with State of Georgia to build EV facilities 05/03/22 Hyundai Motor America reports April retail sales of 61,668 units, down 20% y/y 04/17/22 Hyundai Motor issues first community-based NFT among automakers HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) 05/18/22 Northland SoundHound replacing Cerence at Hyundai, says Northland 06/22/21 Piper Sandler Electric vehicles will represent 94% of new car sales by 2040, says Piper HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) 03/16/22 Wall Street expert calls this small-cap stock the 'new leader' in lidar
Hot Stocks	Ascendis Pharma announces new commercial endocrinology leadership appointments » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) Ascendis Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 08:03 Today Ascendis Pharma announces results from VISEN's Phase 3 trial 03/13/22 Ascendis Pharma announces Phase 3 PaTHway trial of TransCon PTH data 01/13/22 Ascendis Pharma receives European approval for TransCon hGH 01/10/22 Ascendis provides update on Vision 3x3 roadmap, planned 2022 milestones ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/12/22 Cantor Fitzgerald Ascendis Pharma price target lowered to $180 from $230 at Cantor Fitzgerald 05/12/22 Oppenheimer Ascendis Pharma price target lowered to $154 from $166 at Oppenheimer 05/12/22 Wells Fargo Ascendis Pharma price target lowered to $176 from $190 at Wells Fargo 05/12/22 Credit Suisse Ascendis Pharma price target lowered to $123 from $194 at Credit Suisse ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/11/22 Ascendis Pharma reports Q1 EPS EUR (2.21) vs. EUR (1.17) 03/02/22 Ascendis Pharma reportsFY22 EPS (EUR 7.00 ) versus (EUR 8.28) in FY21 02 Sep ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 03/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	Star Equity reports Q1 EPS (5c) vs. (35c) last year » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 STRR Star Equity / + Reports Q1 revenue $25M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Syndicate Events STRR Star Equity / + 04/04/22 KBS Builders wins $9M contract to manufacture four dormitories 04/01/22 Star Equity appoints Rick Coleman as CEO 03/23/22 Star Equity announce intent to nominate director candidates at Gyrodyne 03/02/22 Star Equity announces director nominations at Servotronics STRR Star Equity / + 03/22/22 Star Equity reports Q4 GAAP EPS (84c) vs. (11c) a year ago 20 Jan 10:00 Today Star Equity - STRR 05/31/22 Star Equity Holdings Inc

Hot Stocks	Ascendis Pharma announces results from VISEN's Phase 3 trial » 08:03 05/23/22 05/23 08:03 05/23/22 08:03 ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) Ascendis Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 03/13/22 Ascendis Pharma announces Phase 3 PaTHway trial of TransCon PTH data 01/13/22 Ascendis Pharma receives European approval for TransCon hGH 01/10/22 Ascendis provides update on Vision 3x3 roadmap, planned 2022 milestones 12/14/21 Ascendis to provide update on endocrinology rare disease development programs ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/12/22 Cantor Fitzgerald Ascendis Pharma price target lowered to $180 from $230 at Cantor Fitzgerald 05/12/22 Oppenheimer Ascendis Pharma price target lowered to $154 from $166 at Oppenheimer 05/12/22 Wells Fargo Ascendis Pharma price target lowered to $176 from $190 at Wells Fargo 05/12/22 Credit Suisse Ascendis Pharma price target lowered to $123 from $194 at Credit Suisse ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/11/22 Ascendis Pharma reports Q1 EPS EUR (2.21) vs. EUR (1.17) 03/02/22 Ascendis Pharma reportsFY22 EPS (EUR 7.00 ) versus (EUR 8.28) in FY21 02 Sep ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 03/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Insmed names Drayton Wise as Chief Commercial Officer » 08:03 05/23/22 05/23 08:03 05/23/22 08:03 INSM Insmed $20.27 / +0.69 (+3.52%) , NVS Novartis $89.43 / +0.72 (+0.81%) Insmed (INSM) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events INSM NVS INSM Insmed $20.27 / +0.69 (+3.52%) 03/10/22 Landos Biopharma appoints Roger Adsett to board of directors 02/17/22 Insmed sees FY22 revenue from ARIKAYCE to increase at least 30% y/y NVS Novartis $89.43 / +0.72 (+0.81%) 05/20/22 Novartis reports positive CHMP opinion for expanded use of Cosentyx in children 05/17/22 Xilio Therapeutics appoints Davis as CBO 05/09/22 ADC Therapeutics CEO Chris Martin steps down, Ameet Mallik to succeed 05/05/22 Novartis suspends production at radioligand therapy sites INSM NVS INSM Insmed $20.27 / +0.69 (+3.52%) 04/27/22 Goldman Sachs Insmed initiated with a Buy at Goldman Sachs 12/06/21 JPMorgan Insmed initiated with an Overweight at JPMorgan 11/18/21 Stifel Insmed fits similar 'profile' to Dicerna in terms of value, says Stifel 10/19/21 Morgan Stanley Insmed assumed with an Overweight at Morgan Stanley NVS Novartis $89.43 / +0.72 (+0.81%) 05/13/22 Piper Sandler Point Biopharma price target lowered to $14 from $17 at Piper Sandler 05/13/22 Jefferies Roche downgraded to Hold from Buy at Jefferies 05/09/22 Wolfe Research Novartis downgraded to Peer Perform from Outperform at Wolfe Research 05/06/22 Morgan Stanley Novartis price target raised to CHF 94 from CHF 90 at Morgan Stanley INSM NVS INSM Insmed $20.27 / +0.69 (+3.52%) 05/05/22 Insmed still sees 2022 global revenue growth for Arikayce at least 30% y-o-y 05/05/22 Insmed reports Q1 EPS (80c), consensus (88c) 02/17/22 Insmed reports Q4 EPS (95c), consensus (90c) NVS Novartis $89.43 / +0.72 (+0.81%) 04/26/22 Novartis sees 2022 core operating income to grow mid single digit 04/26/22 Novartis reports Q1 core EPS $1.46, consensus $1.46 02/02/22 Novartis sees 2022 sales, core operating income up mid single digit 02/02/22 Novartis reports Q4 core EPS $1.40 vs. $1.34 last year NVS NVS Novartis $89.43 / +0.72 (+0.81%) 02/10/22 FDA expresses concerns about quality of China-developed drugs, WSJ reports 02/02/22 Novartis CEO says all options are open on Sandoz, FT reports 12/06/21 Novartis at work on pan-coronavirus oral treatment, Reuters reports NVS NVS Novartis $89.43 / +0.72 (+0.81%) 01/19/22 Meet Sangamo: Fly exclusive interview with CEO Sandy Macrae, COO Mark McClung 01/18/22 Fly Intel: Pre-market Movers 12/16/21 Fly Intel: Pre-market Movers 09/19/22 Novartis
Earnings	ReShape Lifesciences reports Q1 EPS (44c) vs. ($1.24) last year » 08:02 05/23/22 05/23 08:02 05/23/22 08:02 RSLS ReShape Lifesciences / + Reports Q1 revenue $2.4M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events RSLS ReShape Lifesciences / + 03/24/22 ReShape announces momentum of DTC marketing campaign for Lap-Band 01/18/22 ReShape Lifesciences to participate in ASMBS meeting 01/13/22 ReShape Lifesciences appoints Michael Bordainick as SVP, Commercial Operations RSLS ReShape Lifesciences / + 03/29/22 Alliance Global Partners ReShape Lifesciences target cut to $5.50 from $10.25 at Alliance Global Partners 03/29/22 Maxim ReShape Lifesciences price target lowered to $4 from $8 at Maxim 10/08/21 Maxim ReShape Lifesciences initiated with a Buy at Maxim 10/08/21 Maxim ReShape Lifesciences initiated with a Buy at Maxim RSLS ReShape Lifesciences / + 03/17/22 ReShape Lifesciences reports 2021 revenue $13.6M, two est. $14.22M 08:30 Today ReShape Lifesciences - RSLS
Initiation	Mitsubishi Motors initiated with a Hold at Jefferies » 08:01 05/23/22 05/23 08:01 05/23/22 08:01 MMTOF Mitsubishi Motors $2.85 / + (+0.00%) Jefferies analyst Takaki… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals MMTOF Mitsubishi Motors $2.85 / + (+0.00%) 04/01/22 Mitsubishi Motors reports Q1 U.S. sales of 26,400 vehicles 01/27/22 Renault-Nissan alliance plans EUR 23B investment in electric cars MMTOF Mitsubishi Motors $2.85 / + (+0.00%) 12/01/21 Citi Mitsubishi Motors downgraded to Sell from Neutral at Citi 07/28/21 CLSA Mitsubishi Motors upgraded to Buy from Outperform at CLSA MMTOF Mitsubishi Motors $2.85 / + (+0.00%) 01/23/22 Renault, Nissan, Mitsubishi to unveil 2030 EV plan this week, Reuters says
Hot Stocks	Entasis Therapeutics Holdings Inc trading halted, news pending 08:00 05/23/22 05/23 08:00 05/23/22 08:00 ETTX Entasis Therapeutics $1.82 / -0.015 (-0.82%) ShowHide Related Items >><< Company News Street Research Earnings On The Fly ETTX Entasis Therapeutics $1.82 / -0.015 (-0.82%) 05/17/22 Entasis Therapeutics presents data highlights from Phase 3 ATTACK trial 04/27/22 Entasis Therapeutics expects cash to fund operations into Q3 of 2022 04/26/22 Entasis Therapeutics presents five poster presentations at ECCMID 04/26/22 Entasis Therapeutics presents data from Phase 3 ATTACK trial at ECCMID ETTX Entasis Therapeutics $1.82 / -0.015 (-0.82%) 05/06/22 Cantor Fitzgerald Entasis Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald 05/06/22 Cantor Fitzgerald Entasis downgraded to Neutral from Overweight at Cantor Fitzgerald 03/16/22 Alliance Global Partners Entasis Therapeutics downgraded to Neutral from Buy at Alliance Global Partners 03/08/22 Wedbush Entasis Therapeutics downgraded to Neutral from Outperform at Wedbush ETTX Entasis Therapeutics $1.82 / -0.015 (-0.82%) 04/27/22 Entasis Therapeutics reports Q1 EPS (32c), consensus (26c) 03/03/22 Entasis Therapeutics reports 2021 EPS ($1.09), consensus ($1.11) ETTX Entasis Therapeutics $1.82 / -0.015 (-0.82%) 03/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Options	Caesars call buyer realizes 31% same-day gains » 08:00 05/23/22 05/23 08:00 05/23/22 08:00 CZR Caesars $50.11 / +1.515 (+3.12%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CZR Caesars $50.11 / +1.515 (+3.12%) 05/16/22 New Jersey reports April gaming revenue up 20% to $422.5M 05/15/22 Caesars Sportsbook named Official Sports Betting Partner of Indy 500, IMS 05/05/22 Caesars announces multiyear partnership with Chicago White Sox 05/03/22 Caesars says labor still tight, but improving CZR Caesars $50.11 / +1.515 (+3.12%) 05/04/22 Jefferies Caesars weakness presents 'compelling' opportunity, says Jefferies 05/04/22 Stifel Caesars price target lowered to $113 from $127 at Stifel 05/04/22 B. Riley B. Riley cuts Caesars target but says shares have 'over-corrected' 05/04/22 Deutsche Bank Caesars price target raised to $105 from $100 at Deutsche Bank CZR Caesars $50.11 / +1.515 (+3.12%) 05/03/22 Caesars reports Q1 same-store adjusted EBITDA $296M vs. $521M last year 05/03/22 Caesars reports Q1 cont ops EPS ($2.11), consensus ($2.21) 05/03/22 Notable companies reporting after market close 02/22/22 Caesars reports Q4 same-store adjusted EBITDA of $581M vs. $348M a year ago CZR Caesars $50.11 / +1.515 (+3.12%) 03/02/22 Apollo in talks to merge Yahoo Sports with betting company, CNBC says 03/01/22 MLB cancels open day as MLBPA rejects offer, AP reports 02/17/22 Hard Rock finds at least three potential sites for NYC casino, AP reports 02/12/22 Boyd, Bally's among stocks to play the online gambling boom, Barron's says CZR Caesars $50.11 / +1.515 (+3.12%) 05/20/22 Bet On It: Kansas legalizes sports betting, aims to launch early 05/06/22 Bet On It: Sportsbooks challenge tribes with second California ballot measure 05/03/22 Fly Intel: After-Hours Movers 04/29/22 Bet On It: Sports betting bills in Massachusetts and Missouri at crossroads 05/25/22 22nd Annual Institutional Investor Conference 06/14/22 Caesars Entertainment, Inc. CZR Caesars $50.11 / +1.515 (+3.12%) 05/20/22 Caesars call volume above normal and directionally bullish 05/13/22 Unusually active option classes on open May 13th 04/13/22 Unusually active option classes on open April 13th 04/04/22 Early notable gainers among liquid option names on April 4th
Hot Stocks	CuriosityStream appoints Peter Westley as CFO succeeding Jason Eustace » 07:59 05/23/22 05/23 07:59 05/23/22 07:59 CURI CuriosityStream $1.63 / -0.03 (-1.81%) CuriosityStream has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events CURI CuriosityStream $1.63 / -0.03 (-1.81%) 04/05/22 Barrington CuriosityStream price target lowered to $7 from $10 at Barrington 03/25/22 DA Davidson CuriosityStream price target lowered to $8 from $23 at DA Davidson 03/25/22 Stifel CuriosityStream price target lowered to $4 from $10 at Stifel 01/21/22 Needham CuriosityStream price target lowered to $6 from $25 at Needham CURI CuriosityStream $1.63 / -0.03 (-1.81%) 05/12/22 CuriosityStream reports Q1 EPS (30c), consensus (33c) 03/24/22 CuriosityStream sees H1 revenue $36M-$40M 03/24/22 CuriosityStream reports Q4 EPS (22c), consensus (31c) CURI CuriosityStream $1.63 / -0.03 (-1.81%) 05/12/22 Fly Intel: After-Hours Movers 03/25/22 What You Missed On Wall Street On Friday 03/25/22 What You Missed On Wall Street This Morning 03/25/22 Fly Intel: Pre-market Movers 07/13/22 CuriosityStream Inc
Recommendations	Stifel trims Deere target to $425, calls post-earnings pullback 'overblown' » 07:58 05/23/22 05/23 07:58 05/23/22 07:58 DE Deere $313.01 / -51.85 (-14.21%) Stifel analyst Stanley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 Deere falls -11.8% 05/20/22 Deere expects Q4 to be highest revenue quarter for the year 05/20/22 Deere sees 'strong' industry demand in 2023 05/20/22 Deere: Q3 material & freight comps should improve 'slightly' DE Deere $313.01 / -51.85 (-14.21%) 07:56 Today Oppenheimer Deere price target lowered to $419 from $446 at Oppenheimer 07:38 Today DA Davidson Deere price target lowered to $445 from $480 at DA Davidson 07:04 Today Credit Suisse Deere price target lowered to $472 from $477 at Credit Suisse 07:02 Today Wells Fargo Deere price target lowered to $410 from $455 at Wells Fargo DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 Deere reports Q2 EPS $6.81, consensus $6.71 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open 02/18/22 Deere reports Q1 EPS $2.92, consensus $2.26 DE Deere $313.01 / -51.85 (-14.21%) 03/22/22 Agriculture stocks see increased demand amid Ukraine turmoil, Bloomberg says 03/19/22 Brinker, Starbucks among stocks to buy among rising food costs, Barron's says 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says 12/04/21 Deere stock could benefit from sustained inflation, Barron's says DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 04/25/22 What You Missed On Wall Street On Monday 07/14/22 Deere 07/15/22 Deere DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 Unusually active option classes on open May 20th 03/11/22 Early notable gainers among liquid option names on March 11th 01/14/22 Deere put volume heavy and directionally bearish 01/05/22 Early notable gainers among liquid option names on January 5th
Recommendations	Deere price target lowered to $419 from $446 at Oppenheimer » 07:56 05/23/22 05/23 07:56 05/23/22 07:56 DE Deere $313.01 / -51.85 (-14.21%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 Deere falls -11.8% 05/20/22 Deere expects Q4 to be highest revenue quarter for the year 05/20/22 Deere sees 'strong' industry demand in 2023 05/20/22 Deere: Q3 material & freight comps should improve 'slightly' DE Deere $313.01 / -51.85 (-14.21%) 07:38 Today DA Davidson Deere price target lowered to $445 from $480 at DA Davidson 07:04 Today Credit Suisse Deere price target lowered to $472 from $477 at Credit Suisse 07:02 Today Wells Fargo Deere price target lowered to $410 from $455 at Wells Fargo 05:55 Today Barclays Deere price target lowered to $400 from $415 at Barclays DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 Deere reports Q2 EPS $6.81, consensus $6.71 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open 02/18/22 Deere reports Q1 EPS $2.92, consensus $2.26 DE Deere $313.01 / -51.85 (-14.21%) 03/22/22 Agriculture stocks see increased demand amid Ukraine turmoil, Bloomberg says 03/19/22 Brinker, Starbucks among stocks to buy among rising food costs, Barron's says 02/26/22 Deere among quality companies doing business mostly in the U.S., Barron's says 12/04/21 Deere stock could benefit from sustained inflation, Barron's says DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 04/25/22 What You Missed On Wall Street On Monday 07/14/22 Deere 07/15/22 Deere DE Deere $313.01 / -51.85 (-14.21%) 05/20/22 Unusually active option classes on open May 20th 03/11/22 Early notable gainers among liquid option names on March 11th 01/14/22 Deere put volume heavy and directionally bearish 01/05/22 Early notable gainers among liquid option names on January 5th
Recommendations	Autodesk price target lowered to $230 from $285 at Stifel » 07:51 05/23/22 05/23 07:51 05/23/22 07:51 ADSK Autodesk $191.41 / -2.575 (-1.33%) Stifel analyst Adam Borg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ADSK Autodesk $191.41 / -2.575 (-1.33%) 03/24/22 Autodesk to acquire The Wild, terms not disclosed 01/19/22 Autodesk acquires Moxion cloud solution 01/06/22 Autodesk names Rebecca Pearce Chief People Officer 12/16/21 Autodesk to acquire ProEst, terms not disclosed ADSK Autodesk $191.41 / -2.575 (-1.33%) 07:09 Today RBC Capital Autodesk price target lowered to $255 from $295 at RBC Capital 06:55 Today Deutsche Bank Deutsche Bank downgrades Autodesk on risk to consensus estimates 05:07 Today Deutsche Bank Autodesk downgraded to Hold from Buy at Deutsche Bank 05/20/22 Citi Autodesk price target lowered to $264 from $286 at Citi ADSK Autodesk $191.41 / -2.575 (-1.33%) 02/24/22 Autodesk reports FY23 EPS $6.46-$6.83, consensus $6.78 02/24/22 Autodesk sees Q1 non-GAAP EPS $1.30-$1.36, consensus 02/24/22 Autodesk reports Q4 non-GAAP EPS $1.50, consensus $1.44 02/24/22 Notable companies reporting after market close ADSK Autodesk $191.41 / -2.575 (-1.33%) 05/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/24/22 Fly Intel: After-Hours Movers 02/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/26/22 Autodesk - ADSK 06/16/22 Autodesk, Inc. ADSK Autodesk $191.41 / -2.575 (-1.33%) 04/25/22 Unusually active option classes on open April 25th 01/25/22 Autodesk put volume heavy and directionally bearish 11/23/21 Autodesk options imply 4.7% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: April 2022 Government Event
Today at 08:30

Chicago Fed National Activity Index: April 2022 Government Event
RSLS
Today at 08:30

ReShape Lifesciences - RSLS Conference Calls
AVPT
Today at 09:00

AvePoint Firm Sponsored Meetings

Virtual Meeting
GILT
Today at 09:30

Gilat Satellite - GILT Conference Calls
HLGN
Today at 10:00

Heliogen - HLGN Conference Calls
STRR
Today at 10:00

Star Equity - STRR Conference Calls
VSTO
Today at 10:00

Vista Outdoor Firm Sponsored Meetings

New York Stock Exchange, New York, NY
AMPS
Today at 10:00

Altus Power Inc Firm Sponsored Meetings
WELL
Today at 10:00

Welltower Inc. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

MarketAxess price target raised to $375 from $369 at Deutsche Bank

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access